These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25874340)

  • 1. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
    Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
    Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
    Salerno L; Pittalà V; Romeo G; Modica MN; Siracusa MA; Di Giacomo C; Acquaviva R; Barbagallo I; Tibullo D; Sorrenti V
    Bioorg Med Chem; 2013 Sep; 21(17):5145-53. PubMed ID: 23867390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.
    Ciaffaglione V; Intagliata S; Pittalà V; Marrazzo A; Sorrenti V; Vanella L; Rescifina A; Floresta G; Sultan A; Greish K; Salerno L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.
    Mucha O; Podkalicka P; Mikulski M; Barwacz S; Andrysiak K; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Ryszawy D; Białas A; Szelążek B; Grudnik P; Majewska E; Michalik K; Jakubiec K; Bień M; Witkowska N; Gluza K; Ekonomiuk D; Sitarz K; Gałęzowski M; Brzózka K; Dubin G; Józkowicz A; Dulak J; Łoboda A
    Arch Biochem Biophys; 2019 Aug; 671():130-142. PubMed ID: 31276659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors.
    Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
    J Med Chem; 2006 Jul; 49(14):4437-41. PubMed ID: 16821802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.
    Greish KF; Salerno L; Al Zahrani R; Amata E; Modica MN; Romeo G; Marrazzo A; Prezzavento O; Sorrenti V; Rescifina A; Floresta G; Intagliata S; Pittalà V
    Molecules; 2018 May; 23(5):. PubMed ID: 29783634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent
    Fallica AN; Sorrenti V; D'Amico AG; Salerno L; Romeo G; Intagliata S; Consoli V; Floresta G; Rescifina A; D'Agata V; Vanella L; Pittalà V
    J Med Chem; 2021 Sep; 64(18):13373-13393. PubMed ID: 34472337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase inhibition by 1-aryl-2-(1h-imidazol-1-yl/1h-1,2,4-triazol-1-yl)ethanones and their derivatives.
    Roman G; Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
    ChemMedChem; 2010 Sep; 5(9):1541-55. PubMed ID: 20652928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase.
    Sugishima M; Higashimoto Y; Oishi T; Takahashi H; Sakamoto H; Noguchi M; Fukuyama K
    Biochemistry; 2007 Feb; 46(7):1860-7. PubMed ID: 17253780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of novel imidazole-dioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells.
    Kinobe RT; Ji Y; Vlahakis JZ; Motterlini R; Brien JF; Szarek WA; Nakatsu K
    J Pharmacol Exp Ther; 2007 Dec; 323(3):763-70. PubMed ID: 17761847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring.
    Roman G; Riley JG; Vlahakis JZ; Kinobe RT; Brien JF; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2007 May; 15(9):3225-34. PubMed ID: 17339115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
    Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R
    J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme oxygenase inhibition by α-(1H-imidazol-1-yl)-ω-phenylalkanes: effect of introduction of heteroatoms in the alkyl linker.
    Vlahakis JZ; Lazar C; Roman G; Vukomanovic D; Nakatsu K; Szarek WA
    ChemMedChem; 2012 May; 7(5):897-902. PubMed ID: 22431362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors.
    Vukomanovic D; McLaughlin B; Rahman MN; Vlahakis JZ; Roman G; Dercho RA; Kinobe RT; Hum M; Brien JF; Jia Z; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2010 Apr; 88(4):480-6. PubMed ID: 20555417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Modulation by Inhibitors of the HO System.
    Fernández-Fierro A; Funes SC; Rios M; Covián C; González J; Kalergis AM
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of rat and mouse microsome heme oxygenase by derivatives of imidazole and benzimidazole.
    Hum M; McLaughlin BE; Kong X; Vlahakis JZ; Vukomanovic D; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1454-1461. PubMed ID: 28793202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
    Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
    Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
    Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring.
    Vlahakis JZ; Hum M; Rahman MN; Jia Z; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2009 Mar; 17(6):2461-75. PubMed ID: 19268600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling.
    Carletta A; Tilborg A; Moineaux L; de Ruyck J; Basile L; Salerno L; Romeo G; Wouters J; Guccione S
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2015 Aug; 71(Pt 4):447-54. PubMed ID: 26208625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.